MD&A Q3_2020 (Eng ) November 2, 2020 Subject : Interim Management Discussion and Analysis of Q3/2020 Attention : President of The Stock Exchange of Thailand We attach herewith the financial

MDA Q3_2019 (Eng ) November 8, 2019 Subject : Interim Management Discussion and Analysis of Q3/2019 Attention : President of The Stock Exchange of Thailand We attach herewith the financial statements

THB 123,675,151.37) 5. Following further negotiations with ACO I, ACO I made an additional offer, i.e. prior to the implementation of the debt to equity conversion scheme, ACO I will make an additional

-634-0135 www.interpharma.co.th Inter Pharma Public Co. Ltd. 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th

, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th Shareholders’ Equity Shareholders’ equity of the Company and its subsidiaries amounted to Baht 465.74 million as at December

., BANGKAE, BANGKAE, BANGKOK, THAILAND. 10160 Tel: 02-455-2888 Fax: 02-455-2763 (“TRANSLATION”) TG 195/2560 November 8, 2017 Subject: Clarification of the Operating Result for the significant change - Update

., BANGKAE, BANGKAE, BANGKOK, THAILAND. 10160 Tel: 02-455-2888 Fax: 02-455-2763 (“TRANSLATION”) TG 048/61 February 27, 2018 Subject: Clarification of the Operating Result for the significant change Attention

., BANGKAE, BANGKAE, BANGKOK, THAILAND. 10160 Tel: 02-455-2888 Fax: 02-455-2763 (“TRANSLATION”) TG 111/2561 May 14, 2018 Subject: Clarification of the Operating Result for the significant change Attention: The

., BANGKAE, BANGKAE, BANGKOK, THAILAND. 10160 Tel: 02-455-2888 Fax: 02-455-2763 (“TRANSLATION”) TG 154/2561 August 8, 2018 Subject: Clarification of the Operating Result for the significant change Attention

. The company plans to open 10 projects each year with potential markets both in Thailand and overseas. On 31 March 2018, the company has 6 hotels under development under the ASAI brand in Thailand